Lv7
3870 积分 2025-07-01 加入
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2天前
已完结
CRISPR technologies for genome, epigenome and transcriptome editing
3天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
5天前
已完结
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease
5天前
已完结
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease
5天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
5天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
5天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
5天前
已完结
Prime assembly with linear DNA donors enables large genomic insertions
15天前
已完结
Prime assembly with linear DNA donors enables large genomic insertions
15天前
已完结
皖公网安备34019202002308
